Join our Free Newsletter and unlock 50% off AltIndexFree newsletter + 50% offJoin free
54 / 100
AltIndex AI Score
Hold
AI Score · 12-mo trend
+4 pts over 3 months67% of MIRA’s tracked signals bullish
FundamentalsBullish
TechnicalsBearish
Alternative dataBullish
SentimentBullish
Price$0.71
Year Range$0.61 – $1.33
Market Cap$31M
IndustryDrug Manufacturers

What Is Mira Pharmaceuticals’s AI Stock Analysis?

Mira Pharmaceuticals’s AI stock analysis on AltIndex combines the company’s fundamentals, price technicals and 25+ alternative data signals — like hiring, web traffic, app downloads and online sentiment — into a single AI Score from 0 to 100 and a plain-English Buy, Hold or Sell read. Unlike a traditional analyst rating that updates a few times a year, the AI Score refreshes as new data arrives, so it tracks Mira Pharmaceuticals’s momentum in near-real time.

Mira Pharmaceuticals (MIRA) has an AltIndex AI Score of 54/100, currently a Hold signal. The AI Score distills Mira Pharmaceuticals's fundamentals, price technicals and 25+ alternative data signals into a single 0–100 rating, so a rising score reflects strengthening data across the board and a falling score the opposite.

Mira Pharmaceuticals’s Full AI Analysis

Mira Pharmaceuticals is a company engaged in the research, development, and commercialization of innovative pharmaceutical products. The firm specializes in producing breakthrough medications, especially in the fields of oncology and immunology. With a focus on high-impact disease areas, Mira Pharmaceuticals aims to improve patient lives through cutting-edge scientific endeavors.

Fundamental Analysis

In the last quarter, Mira Pharmaceuticals reported a net income of $1.2 million. This reflects a decrease of 5.08% from the previous quarter, which could be a cause for concern as it may indicate slowing profitability. However, when compared to the same quarter last year, the net income has increased by 21.41%. This positive year-over-year growth suggests that the company has made significant improvements over a longer-term horizon and is potentially gaining more traction in its market.

Premium

Keep reading AltIndex’s full AI analysis of Mira Pharmaceuticals — the fundamental, technical and alternative-data breakdown and the recommendation.

Sign up to read the full analysis

What’s Driving MIRA’s AI Score?

Fundamentals

Net income for the last quarter was $-1.2M. This represents a decrease of 5.08% compared to the quarter before it, indicating a need for concern. Compared to the same quarter last year, there is an increase of -21.41%, suggesting positive year-over-year growth.

See Mira Pharmaceuticals’s earnings and insider transactions.

Technicals

Today's stock price is $0.71. This represents a decrease of 6.58% compared to a month ago, which may be concerning in the short-term. However, compared to a year ago, there is a decrease of 46.21%, which could be a cause for long-term concern. The trend is bearish. The current SMA10 is $0.77, which is lower than the previous SMA10 of $0.79. This suggests a potential downward trend in price movement. The RSI is 54.9, indicating a neutral condition.

See the full technical analysis and price prediction.

Alternative data

Mira Pharmaceuticals has an estimate of 2,000 visitors to their webpage. The number of visitors is up by 100% in the last couple of months, a bullish trend as this can indicate can increase in customers.

Explore Mira Pharmaceuticals’s job postings, web traffic and app downloads.

Sentiment & social

The sentiment for the stock on various stock forums is neutral. Mira Pharmaceuticals has 14 followers on their Twitter page. The number of followers is up by 8% in the last couple of months, indicating an increased interest in the company.

Track Mira Pharmaceuticals’s market sentiment.

Frequently Asked Questions: Mira Pharmaceuticals AI Stock Analysis

Mira Pharmaceuticals's AltIndex AI Score is 54/100, currently a Hold signal. The AI Score blends fundamentals, technicals and 25+ alternative data signals into a single rating from 0 to 100.

AltIndex's AI Score model rates Mira Pharmaceuticals a Hold (54/100). This is a data-driven signal, not investment advice — review the breakdown above and combine it with your own research.

The AI Score is generated from fundamental data (earnings, valuation), technical indicators (price trend and momentum), and alternative data signals such as hiring, web traffic, app downloads and sentiment. AltIndex weighs these into a single 0-100 score; the exact weighting is proprietary.

AltIndex generates a complete written AI analysis of Mira Pharmaceuticals — company overview, fundamentals, technicals and alternative data, with a recommendation. See the MIRA AI Score or sign up to read the full thesis.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.